Your browser doesn't support javascript.
loading
A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses.
Miah, S M Shahjahan; Lelias, Sandra; Gutierrez, Andres H; McAllister, Mitchell; Boyle, Christine M; Moise, Lenny; De Groot, Anne S.
Afiliación
  • Miah SMS; EpiVax, Inc., Providence, RI, United States.
  • Lelias S; EpiVax, Inc., Providence, RI, United States.
  • Gutierrez AH; EpiVax, Inc., Providence, RI, United States.
  • McAllister M; EpiVax, Inc., Providence, RI, United States.
  • Boyle CM; EpiVax, Inc., Providence, RI, United States.
  • Moise L; EpiVax, Inc., Providence, RI, United States.
  • De Groot AS; EpiVax, Inc., Providence, RI, United States.
Front Immunol ; 14: 1290688, 2023.
Article en En | MEDLINE | ID: mdl-38124752
ABSTRACT
Pathogens escape host defenses by T-cell epitope mutation or deletion (immune escape) and by simulating the appearance of human T cell epitopes (immune camouflage). We identified a highly conserved, human-like T cell epitope in non-structural protein 7 (NSP7) of SARS-CoV-2, RNA-dependent RNA polymerase (RdRp) hetero-tetramer complex. Remarkably, this T cell epitope has significant homology to a T regulatory cell epitope (Tregitope) previously identified in the Fc region of human immunoglobulin G (IgG) (Tregitope 289). We hypothesized that the SARS-CoV-2 NSP7 epitope (NSP7-289) may induce suppressive responses by engaging and activating pre-existing regulatory T cells. We therefore compared NSP7-289 and IgG Tregitopes (289 and 289z, a shorter version of 289 that isolates the shared NSP7 epitope) in vitro. Tregitope peptides 289, 289z and NSP7-289 bound to multiple HLA-DRB1 alleles in vitro and suppressed CD4+ and CD8+ T cell memory responses. Identification and in vitro validation of SARS-CoV-2 NSP7-289 provides further evidence of immune camouflage and suggests that pathogens can use human-like epitopes to evade immune response and potentially enhance host tolerance. Further exploration of the role of cross-conserved Tregs in human immune responses to pathogens such as SARS-CoV-2 is warranted.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos